Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559338 · ClinicalTrials.gov registry record · Phase 4
Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 104
- Enrollment target
NCT00559338: Completed Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
NCT00559338 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 104 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00559338, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.
Interventions
- DRUG placebo
- DRUG recombinant B-type, natriuretic peptide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-04 |
| Phase | Phase 4 |
What the finished NCT00559338 record still lists
NCT00559338 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00559338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00559338 about?
NCT00559338 is a clinical study titled "Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department". The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.
What is the current status of trial NCT00559338?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 104 participants. The study started on 2003-12. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00559338?
The interventions under investigation include: placebo (DRUG), recombinant B-type, natriuretic peptide (DRUG).
Who is sponsoring clinical trial NCT00559338?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00559338's enrollment target sits among peer trials
104 754th of 2000 higher than 1,241 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia